As shown in Figure 4C, the cell viability between the different groups after three days of culture revealed a synergistic anti-tumor effect in combinatorial therapy with BZ and TRAIL, with statistically significant lower cell viability compared to single treatments against RPMI 8226 and MM1.S. This evidence concerns the gene TNFSF10 and neoplasm.